23 unknown, 6 recruiting, 5 completed, 3 not yet recruiting. 34 Not applicable, 4 Phase 1, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 34 | Unknown 23, Completed 5, Recruiting 4, Suspended 2 |
| Phase 1 | 4 | Not yet recruiting 2, Recruiting 2 |
| Early Phase 1 | 1 | Not yet recruiting 1 |
Follow Changping Laboratory: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases PIN+sintilimab - Colorectal Cancer, Adult | Phase 1 | Not yet recruiting | Chinese PLA General Hospital | 25 | 2026-03-01 | 2026-02-17 |
| Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders TMS - Parkinson's Disease, Multiple System Atrophy | Not applicable | Recruiting | Peking University First Hospital | 50 | 2025-12-22 | 2026-06-29 |
| SCAN Targeted Epidural Modulation for Parkinson's Disease Personalized SCAN Targeted Epidural Modulation - Parkinson Disease | Not applicable | Recruiting | Changping Laboratory | 3 | 2025-12-08 | 2026-02-19 |
| PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma PIN +anti-PD1 - Hepatocellular Carcinoma, Adult | Phase 1 | Recruiting | Chinese PLA General Hospital | 25 | 2025-06-20 | 2025-06-22 |
| Allogeneic γδT Cells in Glioblastoma Allogeneic γδ T (ABOUT) cells - Glioblastoma (GBM), Glioblastoma Multiforme (GBM) | Not applicable | Recruiting | Peking University Third Hospital | 18 | 2025-04-01 | 2025-08-27 |
| PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor PIN +anti-PD1 - Solid Tumor, Adult | Phase 1 | Recruiting | Chinese PLA General Hospital | 25 | 2025-03-19 | 2025-06-10 |
| Individualized Functional Imaging-Guided Repetitive Transcranial Magnetic Stimulation (rTMS) for Treating Postural Gait Disorders in Patients with Amyotrophic Lateral Sclerosis (ALS): a Randomized, Crossover, Controlled, Double-Blind Clinical Study Transcranial Magnetic Stimulation - Amyotrophic Lateral Sclerosis (ALS) | Early Phase 1 | Not yet recruiting | Peking University Third Hospital | 45 | 2025-02-14 | 2025-02-11 |
| A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus ATHENA CAR-T, Fludarabine, Cyclophosphamide - Lupus Erythematosus, Systemic | Phase 1 | Not yet recruiting | EdiGene Inc. | 12 | 2024-07-24 | 2024-06-17 |
| pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression active rTMS treatment, sham rTMS treatment - Treatment Resistant Depression, Major Depressive Disorder | Not applicable | Unknown | Changping Laboratory | 270 | 2024-04-17 | 2024-05-07 |
| pBFS Guided rTMS Over Cognitive Control Network for ASD active iTBS treatment, sham iTBS treatment - Autism Spectrum Disorder | Not applicable | Recruiting | Changping Laboratory | 215 | 2024-04-01 | 2025-02-21 |
| pBFS Guided rTMS Over Different Targets for Treatment-Resistant Depression active rTMS stimulating - Major Depressive Disorder, Treatment Resistant Depression | Not applicable | Unknown | Changping Laboratory | 75 | 2024-02-20 | 2024-02-13 |
| Intensive Accelerated iTBS for the Treatment-Resistant Depression Active iTBS-DLPFC, Sham iTBS-DLPFC - Treatment Resistant Depression | Not applicable | Completed | Changping Laboratory | 130 | 2023-12-22 | 2026-05-11 |
| Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique 4 session rTMS, 6 session rTMS, 8 session rTMS - Moderate Depression, Major Depressive Disorder | Not applicable | Suspended | Changping Laboratory | 100 | 2023-12-04 | 2026-05-06 |
| pBFS-guided cTBS Over the Superior Temporal Gyrus for Aphasia After Ischemic Stroke active continuous Theta Burst Stimulation, sham continuous Theta Burst Stimulation - Stroke, Ischemic, Aphasia | Not applicable | Unknown | Changping Laboratory | 40 | 2023-11-07 | 2025-04-04 |
| rTMS Therapy for Treatment-Resistant Depression With Different Targets Guided by pBFS active rTMS - MDD, Major Depressive Disorder | Not applicable | Unknown | Changping Laboratory | 100 | 2023-11-06 | 2024-02-06 |
| pBFS-guided cTBS Combined With iTBS Over the Superior Frontal Gyrus for Aphasia After Ischemic Stroke active cTBS combined with iTBS, sham cTBS combined with iTBS - Stroke, Ischemic, Aphasia | Not applicable | Unknown | Changping Laboratory | 40 | 2023-10-20 | 2023-10-23 |
| pBFS-guided Noninvasive Neuromodulation for Pre-school Children With ASD active iTBS, sham iTBS - Autism Spectrum Disorder | Not applicable | Unknown | Changping Laboratory | 50 | 2023-10-01 | 2023-09-11 |
| pBFS-guided cTBS at Different Doses for Aphasia After Stroke active 1200-pulse continuous Theta Burst Stimulation, active 2400-pulse continuous Theta Burst Stimulation, active 3600-pulse continuous Theta Burst Stimulation - Stroke, Aphasia | Not applicable | Unknown | Changping Laboratory | 60 | 2023-09-22 | 2025-04-04 |
| pBFS Guided rTMS Treating Mild Alzheimer's Disease(AD) active rTMS, sham rTMS - Mild Alzheimer's Disease | Not applicable | Completed | Changping Laboratory | 46 | 2023-09-05 | 2026-06-11 |
| pBFS-Guided rTMS Therapy Over Different Targets for Treatment-Resistant Depression active rTMS stimulating - Major Depressive Disorder, Treatment Resistant Depression | Not applicable | Unknown | Changping Laboratory | 80 | 2023-08-29 | 2024-02-07 |
Showing 20 of 39. Sign in to see all of them.
Depressive Disorder, Major (11) · Aphasia (8) · Depressive Disorder, Treatment-Resistant (8) · Ischemic Stroke (5) · Autism Spectrum Disorder (4) · Depression (4) · Stroke (3) · Obsessive-Compulsive Disorder (2) · Parkinson Disease (2) · Amyotrophic Lateral Sclerosis (1) · Carcinoma, Hepatocellular (1) · Cognitive Dysfunction (1) · Colorectal Neoplasms (1) · Glioblastoma (1) · Learning Disabilities (1)
Transcranial Magnetic Stimulation (2) · Cell Count (1) · Cyclophosphamide (1) · Injections (1) · fludarabine (1) · fludarabine phosphate (1)
China (32)
Hesheng Liu, Ph.D. (19) · Hesheng Liu, PhD (8) · Lilin Ye, Ph.D (3) · Weidong Han, Ph.D (3) · Guanghua Rong, Ph.D (2) · Zhijun Wang, M.D (2) · Hao Zhang, PhD (1) · HeSheng Liu, Ph.D. (1) · Hesheng Liu (1) · Xiaofei Shi, MD (1) · Zhaoxia Wang, M.D. (1)